Research & KnowledgeEvent: September 8, 2026
ImmuneWatch published a Cell Reports paper from the University of Antwerp that profiled 394 individuals across five data layers, including gut bacteria, blood immune cell composition, whole blood transcriptomics, and TCR repertoires.
Published
Signal category
Research & Knowledge
Quote
“A recent Cell Reports paper from the University of Antwerp brings both field together. But maybe not with expected results...”
— Sander Wuyts, PhD 🧬|ImmuneWatch team
Company
ImmuneWatch
The leading software solution for T-cell receptor specificity annotations
- Industry
- Biotechnology Research
- Location
- Antwerp, BE
- Company size
- 7 employees
ImmuneWatch supports academics, clinical-stage biotech and pharma companies by using machine learning to identify T-cell receptor targets and analyse immune responses, helping improve (cancer) vaccines and immunotherapies.
Founded 2021